Ditchcarbon
  • Contact
  1. Organizations
  2. C2I Genomics Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Research Services
US
updated a month ago

C2I Genomics Inc.

Company website

C2I Genomics Inc., headquartered in the United States, is a pioneering force in the genomics industry, specialising in advanced genomic solutions for cancer detection and monitoring. Founded in 2020, the company has rapidly established itself as a leader in the field, leveraging cutting-edge technology to provide unique insights into tumour evolution and treatment response. C2I Genomics offers a range of innovative products and services, including comprehensive genomic profiling and liquid biopsy solutions, which are designed to enhance precision medicine. Their proprietary algorithms and data analytics capabilities set them apart, enabling healthcare providers to make informed decisions based on real-time genomic data. With a commitment to improving patient outcomes, C2I Genomics continues to make significant strides in the oncology landscape, positioning itself as a trusted partner in the fight against cancer.

DitchCarbon Score

How does C2I Genomics Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

C2I Genomics Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

36%

Let us know if this data was useful to you

C2I Genomics Inc.'s reported carbon emissions

C2I Genomics Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported emissions figures. The company is a current subsidiary of Veracyte, Inc., which may influence its climate commitments and initiatives. As of now, C2I Genomics Inc. has not established any documented reduction targets or climate pledges. The lack of specific emissions data and reduction initiatives suggests that the company is in the early stages of developing its climate strategy. Given its affiliation with Veracyte, Inc., it is possible that C2I Genomics may align its climate commitments with those of its parent company, although no specific details have been provided. The company’s future climate actions will be crucial in addressing its environmental impact and contributing to broader industry sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. C2I Genomics Inc.'s primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for C2I Genomics Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

C2I Genomics Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Caris Life Sciences

FR
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 17 days ago

Natera

US
•
Research and development services (73)
Updated 25 days ago

GRAIL, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Geneseeq Technology Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Guardant Health

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Roche Molecular Systems Inc.

US
•
Research and development services (73)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy